Morgan Stanley Maintains Equal-Weight on Exelon, Lowers Price Target to $39
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst David Arcaro maintains an Equal-Weight rating on Exelon (NASDAQ:EXC) but lowers the price target from $41 to $39.
June 24, 2024 | 2:53 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has maintained its Equal-Weight rating on Exelon but has lowered the price target from $41 to $39, indicating a slightly less optimistic outlook.
The lowered price target from $41 to $39 by Morgan Stanley suggests a slightly less optimistic outlook for Exelon. This could lead to a short-term negative impact on the stock price as investors may adjust their expectations accordingly.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100